Wird aktualisiert

The Pharma Letter Podcast

Simon Wentworth

Veröffentlicht: 2025-05-23

Gratis 0%

32 Folgen

Audio

Gratis 0%

32 Folgen

Audio

Veröffentlicht: 2025-05-23

Aktuelle Folge

Why Boehringer and GSK are betting on Ochre

This week on The Pharma Letter Podcast, we’re joined by Quin Wills, co-founder and chief scientific officer of UK biotech Ochre Bio. A physician-scientist with a background in genomics and computational biology, Quin has spent much of his career focu

Länge: 18:53

Abspielen

This week on The Pharma Letter Podcast, we’re joined by Quin Wills, co-founder and chief scientific officer of UK biotech Ochre Bio.

A physician-scientist with a background in genomics and computational biology, Quin has spent much of his career focused on the biology of liver disease — a path that has shaped Ochre’s approach to RNA-based therapies and human-based validation models.

Founded in 2019, the Oxford-based biotech is developing a pipeline of RNA medicines for chronic liver conditions, using live human donor livers to test therapies in real time.

With a focus on regenerative biology and fibrosis, the company’s platform has drawn interest from heavyweights in the industry.

In 2024, Ochre landed a regenerative medicine partnership with Boehringer Ingelheim targeting advanced MASH cirrhosis, and signed a multi-year data licensing deal with GSK to deepen AI models of liver disease.

Backed by Khosla Ventures, the firm raised a $30 million Series A in late 22 and is now progressing its first programs toward IND-enabling studies.

In this week’s episode, we ask Quin about the scientific vision behind Ochre Bio, the state of innovation in liver disease, and where AI is beginning to shift the needle in drug development.

Folgen-ID: 1000709559225

GUID: Buzzsprout-17203856

Erscheinungsdatum: 23.5.2025, 10:00:00

Beschreibung

The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.

Feed-URL

https://feeds.buzzsprout.com/1812337.rss

Apple Podcasts: Kundenrezensionen

Kein Eintrag

Erhältlich auf iTunes. Produktpreise und Verfügbarkeiten beziehen sich auf den 10.6.2025, 09:29:54 und können jederzeit geändert werden. Beim Kauf gelten der Preis und die Verfügbarkeit, wie sie auf iTunes zum Zeitpunkt des Kaufs angezeigt werden. Apple, das Apple Logo, Apple Music, iPad, iPhone, iPod, iPod touch, iTunes, iTunes Store, iTunes U, Mac und OS X sind Marken der Apple Inc., die in den USA und weiteren Ländern eingetragen sind. Apple Books, App Store und Mac App Store sind Dienstleistungsmarken von Apple Inc. IOS ist ein Warenzeichen oder eingetragenes Warenzeichen von Cisco in den USA und anderen Ländern und wird unter Lizenz verwendet. QR Code ist ein eingetragenes Warenzeichen von Denso Wave Incorporated in Japan und anderen Ländern. Alle anderen Warenzeichen, Logos und Urheberrechte sind Eigentum ihrer jeweiligen Inhaber.